Recent Posts
- United Kingdom first to grant license for Teva’s ophthalmology biosimilar Ongavia
- Travere Therapeutics Announced FDA Acceptance and Priority Review of New Drug Application for Sparsentan for the Treatment of IgA Nephropathy
- Inmagene Receives FDA IND Clearance for a Third Generation BTK Inhibitor Targeting Immunological Diseases
- ONT Chosen for Comprehensive Human Genome Program
- Asia’s first molecular diagnostics company for women, INEX Innovate receives European CE-IVD Certification for its OvaCis(R) Rapid Test to detect cancer in ovarian cysts.
Topics
- CFDA
- Classification System
- Clinical Trials
- e-Labeling
- e-Learning
- EMA
- Events
- FDA
- Globalization
- Health
- Healthcare
- In-Country Review
- Innovation
- Interpretation
- Language Service Provider
- Linguistic Validation
- Machine Translation
- Medical Translation
- Medical Writing
- Mistranslations
- Mobile Translation
- News
- Pharmaceuticals
- Quality
- Regulatory
- Resources
- Social Media
- Special stories
- Terminology
- Transcreation
- Website Translation